A patient with urinary retention is admitted to your unit. What may be a causative factor in adult urinary retention?
A) Ureteral pathology
B) Prostatic atrophy
C) Multiple sclerosis
D) Urge incontenence
Ans: C
Feedback: Urinary retention may result from diabetes, prostatic enlargement, urethral pathology (infection, tumor, calculus), trauma (pelvic injuries), pregnancy, or neurologic disorders such as stroke, spinal cord injury, multiple sclerosis, or Parkinson's disease. Urge incontinence could not be a causative factor for urinary retention.
You might also like to view...
Which intervention will increase the patient's likelihood of taking psychotropic medications for the treatment of schizophrenia?
1. Encourage the patient to use measures to manage side effects. 2. Encourage the patient to take all medications at the same time. 3. Give family members information about the patient's medication. 4. Give the patient a pamphlet explaining the positive effects of psychotropic medication.
A patient in her mid-30s has sought advice from her nurse because she has heard conflicting advice about the usefulness of breast self-examination (BSE). What should the nurse teach the patient about the use of BSE as a cancer screening tool?
A) "BSE is falling out of favor because it tends to cause a lot of anxiety for many of the women who practice it." B) "BSE can be a useful tool in detecting cancer because you're most familiar with your own breasts." C) "BSE is often a useful substitute for examinations by your primary care provider." D) "BSE is actually responsible for most of the 'false alarms' around breast cancer diagnosis."
The nurse assesses the patient in traction frequently. What signs or symptoms would the nurse assess for when assessing for a DVT in a traction patient?
A) Increased warmth of the calf B) Decreased circumference of the calf C) Loss of sensation to the calf D) Pale-appearing calf
The nurse is caring for a client who is receiving heparin therapy. How does the nurse evaluate the therapeutic effect of the therapy?
a. Evaluate platelets. b. Monitor the partial thromboplastin time (PTT). c. Assess bleeding time. d. Monitor fibrin degradation products.